A simple method has been developed for the simultaneous analysis of ibuprofen (acid drug), and salbutamol and atenolol (basic drugs) in urine samples at concentrations of 0.40 µg·mL−1. Simultaneous chromatographic separation has been possible using hydrophilic interaction liquid chromatography (Kinetex HILIC® column (2.1 mm × 150 mm, 2.6 μm particle size diameter and 100 Å pore size) combined with gradient elution by employing a mixture of acetonitrile–acetate buffer 5 mM at pH 6 (from 95:5 to 75:25 (v/v)) as the mobile phase. Detection was performed at 227 and 275 nm. The simultaneous preconcentration and cleaning of the sample has been possible by solid-phase extraction using the HLB ExtraBond® polymeric-type sorbent (which is a pyrrolidone-modified divinylbenzene polystyrene type). It has provided recoveries between (63 ± 9)% for salbutamol, (74 ± 8)% for ibuprofen, and (96 ± 9)% for atenolol in 10 mL of synthetic urine containing 4.0 μg of each of the drugs analyzed. The detection limits were 0.025 µg·mL−1 for ibuprofen, µg·mL−1 for salbutamol, and 0.007 µg·mL−1 for atenolol. The detection limits obtained allow the evaluation of the free forms of ibuprofen, atenolol, and salbutamol at the excreted concentration levels at the therapeutic doses usually administered. The coefficients of variation between days were in the range 4.5–10.9%.
Read full abstract